Home / Peptides / KLOW and GLOW blends
KLOW and GLOW blends Dosage: What the Evidence Says (2026)
Not FDA-approved
Seller-defined mixes of GHK-Cu, BPC-157, TB-500 (GLOW) plus KPV (KLOW). No human data for any blend.
Also called: KLOW, GLOW, klow peptide, glow peptide
Regulatory status (US)
Not approved, and no regulator defines what "KLOW" or "GLOW" contain. The October 2026 HHS draft policy only covers single-ingredient products, so multi-peptide blends fall outside it.
What it is
Names sellers use for pre-mixed vials. GLOW is usually described as GHK-Cu + BPC-157 + TB-500, and KLOW as the same plus KPV, but amounts and ingredients vary by seller.
Dosage
KLOW and GLOW blends reconstitution calculator
Enter your vial and your prescribed dose to see the units on a U-100 syringe.
What human studies show
- No human study of any blend.
- See each ingredient: GHK-Cu, BPC-157, TB-500 and KPV.
Safety
- A vial holds several peptides in a fixed ratio, so any dose of one ingredient fixes the dose of the others.
- For the calculator, enter the total mg in the vial only if your dose is also given as total blend mg.
Questions
- Is KLOW and GLOW blends FDA-approved?
- Not approved, and no regulator defines what "KLOW" or "GLOW" contain. The October 2026 HHS draft policy only covers single-ingredient products, so multi-peptide blends fall outside it.
- What dose of KLOW and GLOW blends has been studied?
- There is no established human dose. No human study of any blend. See each ingredient: GHK-Cu, BPC-157, TB-500 and KPV.
- How many units is my KLOW and GLOW blends dose?
- Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.
Related
The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.
BPC-15715-amino-acid peptide studied mostly in animals. Not approved; no established human dose.
TB-500 (thymosin beta-4)Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.
GHK-Cu (copper peptide)Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.
Sources
- Venable LLP: HHS announces interim enforcement discretion for certain peptides (Nov 2026)
- FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)
- FDA 510(k) K212499: BD insulin syringes for U-100 insulin
Last checked 2026-11-16. How we pick and check sources: methodology.